Press release
Monoclonal Antibodies Market 2021 : Latest Development Pfizer, Novartis AG, Bayer AG, Sanofi S.A., F. Hoffmann-La Roche AG
Global Monoclonal Antibodies Market, by Source (Human, Chimeric, Murine, and Humanized), by Application (Cancer, Autoimmune Disease, Hematological Disease, Infectious Disease, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 143.5 billion in 2020 and is expected to exhibit a CAGR of 14.4% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Rising adoption of strategies such as acquisition, collaboration, and license agreement by the market players is expected to bolster the monoclonal antibodies market growth over the forecast period. For instance, in 2018, F. Hoffman-La Roche AG and Kymab Group Ltd entered into a clinical trial agreement to evaluate KY1044 (product of Kymab Group), a human monoclonal antibody, for the treatment of solid tumors. Also, in 2018, Novartis AG entered into a partnership with MorphoSys and Galapagos for the commercialization and development of human immunoglobulin G1 (IgG1) monoclonal antibody targeting interleukin (IL)-17C.
Request PDF Brochure of this report:
https://www.coherentmarketinsights.com/insight/request-pdf/2403
Increasing prevalence of chronic diseases such as cancer is a major factor that is expected to fuel the monoclonal antibodies market growth over the forecast period. For instance, according to the World Cancer Research Fund International’s report, in 2018, breast cancer accounted for the second highest number of cancer cases worldwide, accounting for 2,088,849 new cases worldwide in 2018. Also, according to the National Cancer Institute, 2016, the number of new cancer cases per year is expected to increase to 23.6 million by 2030, worldwide.
Global Monoclonal Antibodies Market – Impact of Coronavirus (Covid-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in over 37.1 million infected individuals worldwide as of 11th October, 2020.
COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channel, and by its financial impact on firms and financial markets.
Clinical trial is rising drastically due to the Covid-19 outbreak. Many market players are collaborating for research and development, in order to develop new monoclonal antibody therapies to address the Covid-19 outbreak. This is expected to drive the market growth over the forecast period. In April 2020, GlaxoSmithKline plc collaborated with Vir Biotechnology, Inc. for the development of coronavirus solutions to combat COVID-19.
In the agreement, Vir’s proprietary monoclonal antibody platform technology is utilized to identify new anti-viral antibodies, which can be used as therapeutic or preventative options to address the current COVID-19 pandemic. In June 2020, AbbVie, Harbour BioMed, Utrecht University, and Erasmus Medical Center announced a collaboration in order to develop a monoclonal antibody therapeutic to prevent and treat COVID-19, caused by the SARS-CoV-2 virus.
Request Here Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/2403
Detailed Segmentation:
Global Monoclonal Antibodies Market, By Source:
Human
Chimeric
Murine
Humanized
Global Monoclonal Antibodies Market, By Application:
Cancer
Autoimmune Disease
Hematological Disease
Infectious Disease
Others
Global Monoclonal Antibodies Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major players operating in the global monoclonal antibodies market include Pfizer Inc., Novartis AG, Bayer AG, Sanofi S.A., F. Hoffmann-La Roche AG, Eli Lilly and Co., Merck & Co., Inc., GlaxoSmithKline Plc., AbbVie Inc., Bristol-Myers Squibb, and Regeneron Pharmaceuticals Inc.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount for Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021:
https://www.coherentmarketinsights.com/insight/buy-now/2403
Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Rising adoption of strategies such as acquisition, collaboration, and license agreement by the market players is expected to bolster the monoclonal antibodies market growth over the forecast period. For instance, in 2018, F. Hoffman-La Roche AG and Kymab Group Ltd entered into a clinical trial agreement to evaluate KY1044 (product of Kymab Group), a human monoclonal antibody, for the treatment of solid tumors. Also, in 2018, Novartis AG entered into a partnership with MorphoSys and Galapagos for the commercialization and development of human immunoglobulin G1 (IgG1) monoclonal antibody targeting interleukin (IL)-17C.
Request PDF Brochure of this report:
https://www.coherentmarketinsights.com/insight/request-pdf/2403
Increasing prevalence of chronic diseases such as cancer is a major factor that is expected to fuel the monoclonal antibodies market growth over the forecast period. For instance, according to the World Cancer Research Fund International’s report, in 2018, breast cancer accounted for the second highest number of cancer cases worldwide, accounting for 2,088,849 new cases worldwide in 2018. Also, according to the National Cancer Institute, 2016, the number of new cancer cases per year is expected to increase to 23.6 million by 2030, worldwide.
Global Monoclonal Antibodies Market – Impact of Coronavirus (Covid-19) Pandemic
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in over 37.1 million infected individuals worldwide as of 11th October, 2020.
COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channel, and by its financial impact on firms and financial markets.
Clinical trial is rising drastically due to the Covid-19 outbreak. Many market players are collaborating for research and development, in order to develop new monoclonal antibody therapies to address the Covid-19 outbreak. This is expected to drive the market growth over the forecast period. In April 2020, GlaxoSmithKline plc collaborated with Vir Biotechnology, Inc. for the development of coronavirus solutions to combat COVID-19.
In the agreement, Vir’s proprietary monoclonal antibody platform technology is utilized to identify new anti-viral antibodies, which can be used as therapeutic or preventative options to address the current COVID-19 pandemic. In June 2020, AbbVie, Harbour BioMed, Utrecht University, and Erasmus Medical Center announced a collaboration in order to develop a monoclonal antibody therapeutic to prevent and treat COVID-19, caused by the SARS-CoV-2 virus.
Request Here Sample Report:
https://www.coherentmarketinsights.com/insight/request-sample/2403
Detailed Segmentation:
Global Monoclonal Antibodies Market, By Source:
Human
Chimeric
Murine
Humanized
Global Monoclonal Antibodies Market, By Application:
Cancer
Autoimmune Disease
Hematological Disease
Infectious Disease
Others
Global Monoclonal Antibodies Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major players operating in the global monoclonal antibodies market include Pfizer Inc., Novartis AG, Bayer AG, Sanofi S.A., F. Hoffmann-La Roche AG, Eli Lilly and Co., Merck & Co., Inc., GlaxoSmithKline Plc., AbbVie Inc., Bristol-Myers Squibb, and Regeneron Pharmaceuticals Inc.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Exclusive offer!!! Purchase the report at a discounted rate!!!
Get Discount for Buyers UPTO 30% OFF On Any Research Report
Buy Now with Discount for Premium Report 2021:
https://www.coherentmarketinsights.com/insight/buy-now/2403
Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
